Rockwell Medical director granted 9,633 stock units

Dawson Joseph H reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 07/06/2026 - 09:26 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Dawson Joseph H reported acquisition or exercise transactions in this Form 4 filing.

Rockwell Medical director Joseph H. Dawson received an equity grant and his holdings were adjusted for a reverse split. On July 1, 2026, he was granted 9,633 shares in the form of restricted stock units at no cash cost. These units vest on July 1, 2027, if he continues serving through the 2027 annual meeting. Effective at 12:01 a.m. on July 1, 2026, Rockwell Medical completed a 1-for-10 reverse split of its common stock, and his existing shareholdings and equity awards were proportionately reduced. After giving effect to both the grant and the reverse split adjustments, Dawson beneficially owns 12,133 shares of common stock directly.

Insider Trade Summary

Grant/Award: 9,633 shares

Grant/Award 1 txn

Insider Dawson Joseph H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,633	$0.00	$0.00

Holdings After Transaction: Common Stock — 12,133 shares (Direct)

Holdings Before and After: Common Stock, 2,500 to 12,133 shares (Direct)

Footnotes (2)

1. F1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.
2. F2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.

Key Figures

RSU grant: 9,633 shares Grant price: $0.00 per share Post-transaction holdings: 12,133 shares +2 more

5 metrics

RSU grant 9,633 shares Restricted stock units granted on July 1, 2026

Grant price $0.00 per share Stated transaction price for RSU grant

Post-transaction holdings 12,133 shares Shares beneficially owned following reported transaction(s)

Reverse split ratio 1-for-10 Common stock reverse split effective July 1, 2026

Vesting date July 1, 2027 RSUs vest subject to continued service through 2027 annual meeting

Key Terms

Restricted stock units, 1-for-10 reverse split, equity awards, Amount of Securities Beneficially Owned Following Reported Transaction(s)

4 terms

Restricted stock units financial

"Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

1-for-10 reverse split financial

"the Issuer effected a 1-for-10 reverse split of the Issuer's common stock"

equity awards financial

"In addition, proportionate adjustments were made to the Issuer's outstanding equity awards."

Equity awards are payments to employees or directors made in the form of company stock or rights to buy stock later, serving as a way to share ownership rather than cash. For investors, they matter because they align staff incentives with company performance, can increase the number of shares outstanding over time (which can reduce each share’s claim on profits), and create compensation costs that affect reported earnings.

Amount of Securities Beneficially Owned Following Reported Transaction(s) financial

"Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Rockwell Medical (RMTI) director Joseph H. Dawson report in this Form 4?

He reported receiving 9,633 shares as a restricted stock unit grant and updated his holdings to 12,133 shares after a 1-for-10 reverse stock split and related equity award adjustments.

How many Rockwell Medical (RMTI) shares were granted to Joseph H. Dawson?

He was granted 9,633 shares in the form of restricted stock units at a stated price of $0.00 per share, indicating a compensation award rather than an open-market purchase.

When do Joseph H. Dawson’s Rockwell Medical (RMTI) restricted stock units vest?

The restricted stock units vest on July 1, 2027, provided Dawson continues to serve Rockwell Medical through the company’s 2027 annual meeting, making this a time-based, service-contingent equity award.

What reverse stock split did Rockwell Medical (RMTI) implement on July 1, 2026?

Effective at 12:01 a.m. on July 1, 2026, Rockwell Medical implemented a 1-for-10 reverse split of its common stock, reducing outstanding shares and proportionately adjusting outstanding equity awards.

How many Rockwell Medical (RMTI) shares does Joseph H. Dawson own after this Form 4 transaction?

Following the grant and the reverse stock split adjustments, Joseph H. Dawson beneficially owns 12,133 shares of Rockwell Medical common stock directly, as reported in the filing.

Was Joseph H. Dawson’s Rockwell Medical (RMTI) grant a market purchase?

No, the 9,633 shares were acquired at a price of $0.00 per share as a restricted stock unit compensation award, not through an open-market purchase on an exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dawson Joseph H

(Last) (First) (Middle)

30142 WIXOM ROAD

(Street)

WIXOM MICHIGAN 48393

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		9,633(1)	A	$0	12,133(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.

2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.

Remarks:

	/s/ Megan Timmins Attorney-In-Fact for Joseph H. Dawson	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)